Reliq Health Technologies (TSXV:RHT.H) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Reliq Health Technologies EBITDA Margin % Related Terms
Reliq Health Technologies EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:RHT.H vs VEEV, GEHC, RCM: EBITDA Margin % Comparison
For the Health Information Services subindustry, Reliq Health Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Reliq Health Technologies EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Reliq Health Technologies's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Reliq Health Technologies's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Reliq Health Technologies (TSXV:RHT.H) has a EBITDA Margin % of -2.56% as of Sep. 2022. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Reliq Health Technologies and its competitors.
Is Reliq Health Technologies' EBITDA Margin % too high?
Reliq Health Technologies' current EBITDA Margin % is -2.56%. Overall, Reliq Health Technologies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Reliq Health Technologies' EBITDA Margin % compare to VEEV and GEHC?
Reliq Health Technologies' EBITDA Margin % of -2.56% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Reliq Health Technologies and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Reliq Health Technologies's current EBITDA Margin % is -2.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reliq Health Technologies stock overvalued right now?
Reliq Health Technologies (TSXV:RHT.H) has a current EBITDA Margin % of -2.56%. The current EBITDA Margin % is -2.56%. Reliq Health Technologies' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Reliq Health Technologies (TSXV:RHT.H), the current EBITDA Margin % is -2.56% as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Reliq Health Technologies Inc specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. The company's IUGO health technology platform is a hardware and software solution that allows complex patients to receive high-quality care in the home, improving health outcomes, enhancing the quality of life for patients and families and reducing the cost of care delivery.
10GF Score
Get the complete analysis for TSXV:RHT.H
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:RHT.H has been successfully added to your 
